Table-2.

The lipid profile of different groups of mice (controls and hyperlipidemic) treated with sweet almond suspension (SAS) in different doses daily for 60 consecutive days.

VLDL-C mg/dl	LDL-C mg/d	HDL-C mg/dl	TAG mg/dl	TC mg/dl	Group
15.90±0.34E	28.31±1.04F	56.30±1.70B	78.22±2.00D	100.77±1.02F	TA (negative control)-distilled water
37.27±0.55A	233.49±4.34A	41.85±0.79D	185.99±4.22A	312.38±2.91A	TB (positive control)-distilled water
36.30±0.38A	225.92±3.85AB	44.19±0.90D	179.18±3.98A	305.88±2.29B	T1 (SAS 285 mg/kg, orally)
29.25±0.59B	223.16±3.90B	48.63±0.71C	138.98±2.00B	299.50±2.25B	T2 (SAS 571 mg/kg, orally)
22.99±0.34C	166.95±3.34C	51.17±0.78C	115.00±1.75C	241.11± 3.00C	T3 (SAS 857 mg/kg, orally)
18.76±0.24D	89.52±2.34D	57.19±0.60B	93.81±2.25D	164.73±2.77D	T4 (SAS 1128 mg/kg, orally)
16.73±0.32E	48.30±1.98E	61.20±0.47A	84.62±1.76D	124.74±2.07E	T5 (SAS 1428 mg/kg, orally)

n=10 mice/group. Different letters in a column refer to significant differences among the groups (p<0.05). TB and T1-T5-hyperlipidemic mice. Values represent mean±SE